Largest biotech companies by total debt

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

Amgen leads the 11 biotech companies ranked by total debt, at SAR 204.8B, ahead of Gilead Sciences (SAR 93.5B) and Biogen (SAR 23.6B). Figures as of 18 Nov 2026, 19:21 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
11
First
AmgenSAR 204.8B
Median
SAR 2.2B
Combined market value
SAR 3.14T
Countries
5
Not ranked
13no total debt on file

Market values as of .

All countries
All sectors
Biotech
SAR
Clear filters
Largest biotech companies by total debt
#CompanyTotal debt ↓Market capPriceToday1 yearPrice, 30 daysCountry
1AmgenAMGN · Health CareSAR 204.8BSAR 897.6BSAR 1,659.40 3.39% down 34% up United States
2Gilead SciencesGILD · Health CareSAR 93.5BSAR 783.5BSAR 631.67 1.09% down 33% up United States
3BiogenBIIB · Health CareSAR 23.6BSAR 139BSAR 940.00 0.08% down 49% up United States
4Halozyme TherapeuticsHALO · Health CareSAR 8BSAR 41.2BSAR 361.18 0.33% up 37% up United States
5QiagenQGEN · Health CareSAR 6.2BSAR 38.5BSAR 186.37 0.13% down 12% up Netherlands
6ModernaMRNA · Health CareSAR 2.2BSAR 301.8BSAR 745.92 3.84% down 755% up United States
7RepligenRGEN · Health CareSAR 2BSAR 41BSAR 641.44 5.44% up 5% up United States
8Bio-TechneTECH · Health CareSAR 750.2MSAR 42.9BSAR 273.00 0.21% up 26% up United States
9Adaptive BiotechnologiesADPT · Health CareSAR 492.2MSAR 17.3BSAR 106.92 0.05% up 88% up United States
10Scholar Rock HoldingSRRK · Health CareSAR 374MSAR 21.8BSAR 178.89 5.79% up 14% up United States
11CG OncologyCGON · Health CareSAR 11.3MSAR 26.6BSAR 297.60 0.51% up 85% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Total debt is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Total debt is assembled from each company's debt lines and is the least complete of these figures: some companies tag part of their borrowings in ways it misses. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7510 SAR). 13 companies have no total debt on file and are not ranked here.

Questions and answers

Which biotech companies rank first by total debt?

Amgen (SAR 204.8B), Gilead Sciences (SAR 93.5B) and Biogen (SAR 23.6B) are the top three of the 11 biotech companies ranked by total debt as of 18 Nov 2026, 19:21 UTC.

How many biotech companies are in this ranking?

11 are ranked by total debt. 13 more have no total debt on file and are left out rather than ranked at zero.

What are these biotech companies worth together?

The 11 biotech companies ranked by total debt have a combined market value of SAR 3.14T as of 18 Nov 2026, 19:21 UTC.

What does ranking by total debt measure?

Borrowings at the end of the latest fiscal year: long-term debt including the part due within a year, plus short-term borrowings. Leases are left out unless the company reports them in one figure with its debt.

Cite this page

Funkfolio, “Largest biotech companies by total debt”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=total-debt

Underlying data: Yahoo Finance; SEC EDGAR.